Join us for a NAACCR Talk Series "MedMorph: New/Improved EHR Reporting and What it Means for My Central Cancer Registry"
Registration is free at:
In this series we intend to inform the central cancer registries about a new EHR reporting initiative and how it is transforming the way EHR data are being reported to public health. Making EHR Data More Available for Research and Public Health (MedMorph) leverages HL7 Fast Healthcare Interoperability Resources (FHIR), which has been developed and implemented by EHR vendors and is ready for central cancer registries to join the FHIRfight to improve completeness and timeliness.
Session 1: What is MedMorph and Why do We Care?
Date: August 2, 2021 at 2-3:00pm ET
This webinar focuses on what Making EHR Data More Available for Research and Public Health (MedMorph) is, why the cancer community is involved, how MedMorph is different from other EHR reporting initiatives, and when MedMorph is happening.
Session 2: In Depth Review of the MedMorph Central Cancer Registry Reporting Use Case Implementation Guide (IG)
Date: Part 1 August 23, 2021 at 2-3:30pm ET
Date: Part 2 August 30, 2021 at 2-3:30pm ET
This session will be an interactive group discussion of the draft implementation guide (IG) being prepared for HL7 balloting. The review will include topics such as: whether the list of data elements is appropriate; whether a data element is required or optional for reporting; and value set selection, workflow, and triggers.
· David Jones, PhD; Health Scientist (Informatics), CDC
· Wendy Scharber, RHIT, CTR; Registry Widgets, CDC Consultant
· Gakeria Kirton, ORISE Cancer Surveillance Informatics Fellow, CDC
· Becky Angeles, BS; Senior Healthcare Analyst, Carradora Health
Angela Martin, CTR
Training Specialist/Project Coordinator
Phone: 217-698-0800 ext. 9